Answer
Rifampicin reduced Saxagliptin peak blood concentration (Cmax) by 53% and overall exposure (AUC) by 76%, without affecting exposure to its active metabolite or plasma DPP4 inhibition over a dosing interval.
Sources for this answer
- Saxagliptin 2.5 mg Film-coated TabletsCelix Pharma Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked